Oct 30, 2020
Ionis and Akcea win prestigious Prix Galien Award for TEGSEDI® (inotersen) as Best Biotechnology Product
Sep 05, 2020
Kaskela Law LLC Announces Stockholder Investigation of Akcea Therapeutics, Inc. (AKCA) and Encourages Investors to Contact the Firm
Aug 18, 2020
Akcea and Ionis to Present Phase 2 Results of AKCEA-APOCIII-L(Rx) in Late-Breaking Presentation at ESC Congress 2020
Aug 13, 2020
Akcea Announces New Pricing and Reimbursement of WAYLIVRA® (volanesorsen) in Germany
Aug 04, 2020
Akcea Reports Financial Results and Highlights for Second Quarter 2020
Jul 22, 2020
Akcea Announces Approval for Reimbursement of TEGSEDI® (inotersen) in Austria for Treatment of Hereditary Transthyretin Amyloidosis with Polyneuropathy
Jul 21, 2020
Akcea Therapeutics to Hold Second Quarter 2020 Financial Results Webcast
Jul 20, 2020
Akcea Appoints New Senior Vice President, Global Medical Affairs
Jul 09, 2020
Akcea Announces Appointment of New Chief Medical Officer
Jun 29, 2020
Akcea Appoints Tracy Palmer Berns as Chief Compliance Officer
Jun 17, 2020
Akcea Therapeutics to Present at the BMO 2020 Prescriptions for Success Healthcare Conference
Jun 09, 2020
Akcea Appoints New Senior Vice President, Business Development and Corporate Strategy
Jun 08, 2020
Akcea announces approval for reimbursement of TEGSEDI® (inotersen) in Italy for treatment of hereditary transthyretin amyloidosis with polyneuropathy
May 18, 2020
Akcea Announces Appointment of New Chief Financial Officer
May 14, 2020
Akcea Announces Approval for Reimbursement of TEGSEDI® (inotersen) in Spain for Treatment of Hereditary Transthyretin Amyloidosis with Polyneuropathy
May 07, 2020
Akcea Expands Leadership Team with Appointment of Carla Poulson as Senior Vice President and Chief Human Resources Officer
May 05, 2020
Akcea Reports Financial Results and Highlights for First Quarter 2020
Jan 22, 2020
Akcea and Ionis report positive topline Phase 2 results of AKCEA-APOCIII-L Rx
Mar 04, 2019
PTC to Expand Product Portfolio in Latin America with WAYLIVRA(TM)
Aug 02, 2018
Akcea Therapeutics and PTC Therapeutics Collaborate to Commercialize Two Rare Disease Drugs in Latin America